Cadrenal Therapeutics Inc... (CVKD)

NASDAQ: CVKD · Real-Time Price · USD

16.70

0.20 (1.21%)

At close: May 02, 2025, 11:34 AM

Cadrenal Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-10.65M	-8.36M	-6.71M
Depreciation & Amortization	1.88K	1.98K	1.27K
Stock-Based Compensation	1.42M	710.38K	n/a
Other Working Capital	538.1K	381.89K	202.84K
Other Non-Cash Items	-352	3.97M	4.5M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	1.87M	144.31K	607.74K
Operating Cash Flow	-7.36M	-3.53M	-1.2M
Capital Expenditures	n/a	-3.25K	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-2.28K
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	-6.54K	n/a	n/a
Investing Cash Flow	-6.54K	-3.25K	-2.28K
Debt Repayment	n/a	-250K	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	3.84M	250K	n/a
Financial Cash Flow	8.98M	11.9M	1.24M
Net Cash Flow	1.62M	8.37M	32.59K
Free Cash Flow	-7.36M	-3.53M	-1.2M